First Trust Advisors’s AngioDynamics ANGO Stock Holding History

First Trust Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-41,709	Closed	-$928K	–	2427
2018 Q2	$928K	Buy	41,709 +6,414	+18%	+$131K	﹤0.01%	1968
2018 Q1	$609K	Buy	35,295 +2,429	+7%	+$40.5K	﹤0.01%	1975
2017 Q4	$547K	Buy	32,866 +3,968	+14%	+$67.7K	﹤0.01%	2059
2017 Q3	$494K	Buy	+28,898	New	+$485K	﹤0.01%	2089
2016 Q4	–	Sell	-31,578	Closed	-$554K	–	2417
2016 Q3	$554K	Buy	+31,578	New	+$512K	﹤0.01%	1966
2016 Q2	–	Sell	-33,099	Closed	-$407K	–	2273
2016 Q1	$407K	Buy	33,099 +2,614	+9%	+$28.9K	﹤0.01%	1999
2015 Q4	$370K	Buy	+30,485	New	+$375K	﹤0.01%	2040
2014 Q3	–	Sell	-15,016	Closed	-$245K	–	2222
2014 Q2	$245K	Sell	15,016 -6,476	-30%	-$93.7K	﹤0.01%	2097
2014 Q1	$338K	Buy	21,492 +354	+2%	+$5.77K	﹤0.01%	2052
2013 Q4	$363K	Sell	21,138 -13,606	-39%	-$209K	﹤0.01%	2002
2013 Q3	$459K	Sell	34,744 -9,480	-21%	-$112K	﹤0.01%	1944
2013 Q2	$499K	Buy	+44,224	New	+$471K	﹤0.01%	1801

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

First Trust Advisors's ANGO Position: Q3 2018 in Review

First Trust Advisors sold out of AngioDynamics (ANGO) in Q3 2018, closing a stake of 41,709 shares — an estimated $928K sold.

First Trust Advisors first reported a position in ANGO in Q2 2013 and held it in 12 quarters. The position peaked at $928K in Q2 2018. 177 funds tracked by Wall St. Rank hold ANGO as of Q3 2018.

First Trust Advisors reported no remaining AngioDynamics position as of Q3 2018 after selling out during the quarter.
First Trust Advisors sold 41,709 AngioDynamics shares in Q3 2018, an estimated $928K.
First Trust Advisors first reported a position in AngioDynamics in Q2 2013 and held it in 12 quarters.
First Trust Advisors's AngioDynamics position peaked at $928K in Q2 2018.
177 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2018.

Based on First Trust Advisors's 13F filing for Q3 2018, filed 25 Oct 2018.